Phase 3 Breast Carcinoma Clinical Trials
3 recruitingPhase 3
What is a Phase 3 trial?
Phase 3 trials compare the new treatment against the current standard of care in large groups, often hundreds to thousands of participants. Successful Phase 3 results are typically required for regulatory approval.
Showing 1–3 of 3 trials
Recruiting
Phase 3
ECLECTIC: EstroTEP and Circulating Biomarkers for ER-positive HER2-negative Metastatic Breast Cancer Patients
Breast Carcinoma
Institut Curie300 enrolled13 locationsNCT06195709
Recruiting
Phase 3
A Study of a Comprehensive Prevention Program to Reduce Lymphedema After Axillary Lymph Node Dissection in People With Breast Cancer
Breast CancerBreast CarcinomaLymphedema+3 more
Memorial Sloan Kettering Cancer Center285 enrolled7 locationsNCT06144164
Recruiting
Phase 3
Hypofractionated Postoperative Regional Nodal Irradiation for Patients With Intermediate-risk Breast Cancer
Breast Carcinoma
Cancer Institute and Hospital, Chinese Academy of Medical Sciences3,142 enrolled1 locationNCT06757621